Curad Maximum Strength Triple Antibiotic Ointment
NDC Package 53329-031-01
Package Information
Curad Maximum Strength Triple Antibiotic (bacitracin, neomycin, polymyxin b, pramoxine hydrochloride) ointment is adults and children 2 years and older:clean affected areaapply a small amount (equal to the surface area of tip of finger) on area 1 to 3 times dailymay be covered with a sterile bandage.Children under 2 years: ask a doctor. This formulation utilizes a ointment delivery system. Marketed by Medline Industries, Lp, this product is identified by NDC 53329-031 and is authorized under FDA application M004.
Identification & Billing
- RxCUI: 1359350 - bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG in GM Topical Ointment
- RxCUI: 1359350 - bacitracin 0.5 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment
- RxCUI: 1359350 - bacitracin 500 UNT / neomycin 3.5 MG / polymyxin B 10,000 UNT / pramoxine HCl 10 MG per GM Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 53329 - Medline Industries, Lp
- 53329-031 - Curad Maximum Strength Triple Antibiotic
- 53329-031-01 - 1 TUBE in 1 BOX / 28.4 g in 1 TUBE
- 53329-031 - Curad Maximum Strength Triple Antibiotic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53329-031-01 identifies a specific commercial package of 1 tube in 1 box / 28.4 g in 1 tube of Curad Maximum Strength Triple Antibiotic, a human over the counter drug labeled by Medline Industries, Lp. This ointment is formulated for topical use and contains bacitracin zinc; neomycin sulfate; polymyxin b sulfate; pramoxine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medline Industries, Lp on December 01, 2019. The current certification is valid through December 31, 2026.
How is this Medline Industries, Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53329003101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.